Jens Juul Holst
Jens Juul Holst is a professor at the Department of Biomedical Sciences and at the same time affiliated with the Novo Nordisk Foundation Center for Basic Metabolic Research. Jens Juul Holst's research concentrates on appetite regulation and hormones that regulate metabolism (digestion).
Jens is head of a research group that focuses on obesity and type 2 diabetes, especially with the aim of mapping hormonal disorders and the possibilities of treatment based on hormones. He has also taken part in developing a wide range of drugs used in treatment of type 2 diabetes.
Jens is co-founder of start-ups, including Antag Therapeutics and Bainan Biotech. BMI collaborate with Antag Therapeutics and Bainan Biotech on a variety of research projects with the aim of generating new knowledge that can be used in the prevention and treatment of diseases.